BioNTech SE ADR rises Thursday, still underperforms market

Company Logo

Terrence Horan

Referenced Symbols

The BioNTech SE ADR BNTX, +2.50% inched 0.37% higher to $250.33 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX, +0.37% rising 1.71% to 4,438.26 and the Dow Jones Industrial Average DJIA, +0.43% rising 1.56% to 34,912.56. This was the ADR's third consecutive day of gains. BioNTech SE ADR closed $213.67 below its 52-week high ($464.00), which the company reached on August 10th.

The ADR underperformed when compared to some of its competitors Thursday, as AbbVie Inc. ABBV, +0.89% rose 1.57% to $108.91 and Amgen Inc. AMGN, +1.39% rose 1.56% to $206.78. Trading volume (1.7 M) remained 2.4 million below its 50-day average volume of 4.1 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.